Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Diabetes Mellitus, Type 2 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × saxagliptin × Clear all
NCT07363863 2026-01-23

Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma

Sohag University

Not yet recruiting
100 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02022007 2017-06-28

BMS-AZPCOS

Woman's

Phase 3 Completed
38 enrolled 17 charts

Polycystic Ovary Syndrome

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡